# Orbera365 Intragastric Balloon System (Abbreviated as'Orbera365')

> **NCT07195708** · NA · NOT_YET_RECRUITING · sponsor: **Boston Scientific Corporation** · enrollment: 144 (estimated)

## Conditions studied

- Weight Loss

## Interventions

- **DEVICE:** Treatment group

## Key facts

- **NCT ID:** NCT07195708
- **Lead sponsor:** Boston Scientific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05-30
- **Primary completion:** 2028-04-30
- **Final completion:** 2028-10-31
- **Target enrollment:** 144 (ESTIMATED)
- **Last updated:** 2026-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07195708

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07195708, "Orbera365 Intragastric Balloon System (Abbreviated as'Orbera365')". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07195708. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*